Full text loading...
-
Sodium Acetate-promoted Oxa-Michael-Aldol [3+2] Annulation Reactions: Facile Access to the Fused Heterocycle
- Source: Current Catalysis, Volume 7, Issue 1, Apr 2018, p. 60 - 64
-
- 01 Apr 2018
Abstract
Background: The development of simple yet efficient functionalization protocols has gained considerable importance for the discovery of useful heterocycle compounds, such as isoxazolo, isoindol and their derivatives. 3a-hydroxyisoxazolo[3,2-a]isoindol-8(3aH)-ones are a type of novel heterocycles first reported by Lu group involving Ph3P-catalyzed annulation process. In this work, we aim to explore the synthesis of this novel complex heterocycles using simple base catalyst from internal alkynoates with N-hydroxyphthalimide. Methods: The reactions were conducted in the Schlenk flasks, protected by N2. The products were identified by TLC, and isolated by column chromatography on silica gel (200-300 mesh) using petroleum ether (60-90 °C) and ethyl acetate. All products were characterized by 1H NMR, 13C NMR and mass spectroscopy. Results: A highly active base-promoted system based on NaOAc•3H2O has been designed for the oxa- Michael-aldol [3+2] annulation reactions of internal alkynoates with N-hydroxyphthalimide, giving a series of pharmaceutically attractive 3a-hydroxyisoxazolo[3,2-a]isoindol-8(3aH)-ones in synthetically useful yields of up to 98%. Only 10 mol% NaOAc•3H2O is needed for the reaction at room temperature within 6 h. Besides, a plausible base-promoted intermolecular [3+2] oxa-Michael-aldol type mechanism is proposed. Conclusions: We have demonstrated the simple cascade reaction between alkynoates and NHPI as a facile access to pharmaceutically attractive 3a-hydroxyisoxazolo[3,2-a]isoindol-8(3aH)-ones, with a base-promoted intermolecular [3+2] oxa-Michael-aldol type mechanism. Target heterocycles with various functional groups were achieved in good to excellent yields at room temperature for 6 h. Such a synthetic methodology provides an effective approach of the synthesis of the fused heterocyclics in combination with CO2 utilization.